• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素 6 的上调参与了中高热诱导的肝癌细胞的增殖和侵袭。

Upregulation of IL-6 is involved in moderate hyperthermia induced proliferation and invasion of hepatocellular carcinoma cells.

机构信息

Department of Radiology, The First Affiliated Hospital, Zhengzhou University, No. 1, East Jian She Road, Zhengzhou 450052, Henan Province, People's Republic of China.

Department of Radiology, The First Affiliated Hospital, Zhengzhou University, No. 1, East Jian She Road, Zhengzhou 450052, Henan Province, People's Republic of China.

出版信息

Eur J Pharmacol. 2018 Aug 15;833:230-236. doi: 10.1016/j.ejphar.2018.06.014. Epub 2018 Jun 9.

DOI:10.1016/j.ejphar.2018.06.014
PMID:29894725
Abstract

Increasing evidences suggested that insufficient radiofrequency ablation (RFA) can paradoxically promote tumor invasion and metastatic processes, while the effects of moderate hyperthermia on cancer progression are not well illustrated. Our present study confirmed moderate hyperthermia treatment can promote the proliferation, migration and invasion of hepatocellular carcinoma (HCC) cells, which was evidenced by the results that moderate hyperthermia induced up regulation of proliferating cell nuclear antigen (PCNA) and matrix metalloproteinase-2 (MMP-2). Cellular studies indicated that moderate hyperthermia treatment can increase the mRNA and protein expression of IL-6 and IL-10, while not IL-2, IL-4, IL-8, IL-22, VEGF, TGF-β, or TNF-α, in HCC cells. Silencing of IL-6, while not IL-10, attenuated moderate hyperthermia treatment induced proliferation and cell invasion. Furthermore, our data revealed the inhibition of NF-κB, while not ERK1/2 or PI3K/Akt, abolished moderate hyperthermia treatment induced production of IL-6. Collectively, our data showed that activation of NF-κB/IL-6 is involved in moderate hyperthermia treatment induced progression of HCC cells.

摘要

越来越多的证据表明,射频消融(RFA)不足会反常地促进肿瘤侵袭和转移过程,而适度热疗对癌症进展的影响则尚未得到充分说明。我们的研究证实,适度热疗可促进肝癌(HCC)细胞的增殖、迁移和侵袭,这一结果表明适度热疗诱导了增殖细胞核抗原(PCNA)和基质金属蛋白酶-2(MMP-2)的上调。细胞研究表明,适度热疗可增加 HCC 细胞中 IL-6 和 IL-10 的 mRNA 和蛋白表达,但不增加 IL-2、IL-4、IL-8、IL-22、VEGF、TGF-β或 TNF-α的表达。沉默 IL-6 而不是 IL-10 可减弱适度热疗诱导的增殖和细胞侵袭。此外,我们的数据显示,NF-κB 的抑制作用,而不是 ERK1/2 或 PI3K/Akt 的抑制作用,可消除适度热疗诱导的 IL-6 产生。总之,我们的数据表明,NF-κB/IL-6 的激活参与了适度热疗诱导的 HCC 细胞进展。

相似文献

1
Upregulation of IL-6 is involved in moderate hyperthermia induced proliferation and invasion of hepatocellular carcinoma cells.白细胞介素 6 的上调参与了中高热诱导的肝癌细胞的增殖和侵袭。
Eur J Pharmacol. 2018 Aug 15;833:230-236. doi: 10.1016/j.ejphar.2018.06.014. Epub 2018 Jun 9.
2
After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.射频消融不足后,肿瘤相关内皮细胞表现出增强的血管生成作用,并促进残余肝细胞癌的侵袭性。
J Transl Med. 2012 Nov 21;10:230. doi: 10.1186/1479-5876-10-230.
3
NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.核因子-κB增强17β-羟基类固醇脱氢酶4的表达,通过使雌二醇失活促进肝癌细胞系HepG2增殖。
Mol Cell Endocrinol. 2015 Feb 5;401:1-11. doi: 10.1016/j.mce.2014.11.016. Epub 2014 Nov 28.
4
Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.真核生物延伸因子-1α 2基因敲低通过抑制PI3K/Akt/NF-κB信号传导抑制肝癌发生。
World J Gastroenterol. 2016 Apr 28;22(16):4226-37. doi: 10.3748/wjg.v22.i16.4226.
5
IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.IL-33 通过 NF-κB 和 ERK1/2 信号通路上调 CCL2/CCR2 增强了蜕膜基质细胞的增殖和侵袭能力。
Mol Hum Reprod. 2014 Apr;20(4):358-72. doi: 10.1093/molehr/gat094. Epub 2013 Dec 15.
6
Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-κB/IL-6 signals.内脂素通过激活NF-κB/IL-6信号触发骨肉瘤细胞的体外迁移。
Eur J Pharmacol. 2016 Nov 15;791:322-330. doi: 10.1016/j.ejphar.2016.08.029. Epub 2016 Aug 26.
7
Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.甘露糖介导的PA-MSHA通过EGFR/Akt/IκBβ/NF-κB途径对肝癌侵袭和转移的抑制作用。
Liver Int. 2015 Apr;35(4):1416-29. doi: 10.1111/liv.12644. Epub 2014 Aug 21.
8
Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.乙型肝炎病毒X蛋白通过NF-κB和Notch1途径促进白细胞介素-7受体表达,以促进乙型肝炎病毒相关肝癌细胞的增殖和迁移。
J Exp Clin Cancer Res. 2016 Nov 7;35(1):172. doi: 10.1186/s13046-016-0448-2.
9
Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.微小RNA-16对肝癌细胞增殖、侵袭和转移的抑制作用。
Int J Mol Med. 2015 Dec;36(6):1713-9. doi: 10.3892/ijmm.2015.2379. Epub 2015 Oct 16.
10
S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.S100A4 通过 NF-κB 依赖性 MMP-9 信号调控肝癌 HepG2 细胞的迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2372-82.

引用本文的文献

1
Radiofrequency ablation: mechanisms and clinical applications.射频消融:机制与临床应用
MedComm (2020). 2024 Oct 2;5(10):e746. doi: 10.1002/mco2.746. eCollection 2024 Oct.
2
Upregulation of EFCAB7 after radiofrequency ablation promoting hepatocellular carcinoma metastasis and survival by regulating PARK7.射频消融后 EFCAB7 的上调通过调节 PARK7 促进肝癌转移和存活。
Aging (Albany NY). 2024 Sep 12;16(17):12252-12262. doi: 10.18632/aging.206073.
3
Differential cytokine and chemokine expression after ablation vs. resection in colorectal cancer liver metastasis.
结直肠癌肝转移中消融与切除术后细胞因子和趋化因子的差异表达
Surg Open Sci. 2024 Jan 14;18:29-34. doi: 10.1016/j.sopen.2024.01.005. eCollection 2024 Mar.
4
Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation.热消融后肝细胞癌复发与进展的机制及治疗策略
J Interv Med. 2023 Oct 18;6(4):160-169. doi: 10.1016/j.jimed.2023.10.004. eCollection 2023 Nov.
5
Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.放大癌症治疗:肿瘤免疫治疗和基于纳米粒子的热疗的进展。
Front Immunol. 2023 Oct 6;14:1258786. doi: 10.3389/fimmu.2023.1258786. eCollection 2023.
6
The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma.介入区域性治疗与免疫治疗联合治疗肝细胞癌的协同作用。
Int J Mol Sci. 2023 May 11;24(10):8598. doi: 10.3390/ijms24108598.
7
How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles.生物学如何指导肝细胞癌局部区域介入治疗与免疫治疗的联合应用:细胞因子及其作用
Cancers (Basel). 2023 Feb 19;15(4):1324. doi: 10.3390/cancers15041324.
8
Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.纤维化肝脏的炎症微环境通过 STAT3 激活促进肝癌生长、转移和索拉非尼耐药。
J Cell Mol Med. 2021 Feb;25(3):1568-1582. doi: 10.1111/jcmm.16256. Epub 2021 Jan 7.
9
Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors.肿瘤微环境热疗促进免疫检查点抑制剂的应用
Front Immunol. 2020 Nov 9;11:595207. doi: 10.3389/fimmu.2020.595207. eCollection 2020.
10
Silencing CDC25A inhibits the proliferation of liver cancer cells by downregulating IL‑6 in vitro and in vivo.沉默 CDC25A 通过下调体外和体内的 IL-6 抑制肝癌细胞的增殖。
Int J Mol Med. 2020 Mar;45(3):743-752. doi: 10.3892/ijmm.2020.4461. Epub 2020 Jan 9.